NEW YORK: Two pharmaceutical giants are pitching PR business worth
millions of pounds in a search for PR help surrounding the launch of
blockbuster drugs being launched in the US. French-German firm Aventis
is looking for PR assistance for insulin tablet Amaryl and newcomer
Lantus. Schering-Plough needs an agency to handle PR for its new
hayfever drug Clarinex.